Lisa Boggio, MD

Rush University Medical CenterChicago, Illinois - 60612 |
- CLINICAL TRIALS 1
- CONDITIONS2
- INTERVENTIONS1
- SINCE2009

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor
March 2009 - September 2012
Hemophilia A
Hemophilia B
Factor Viii Inhibitor Bypassing Activity (Nanofiltered, Vapor Heat-Treated)



